Completed NA INTERVENTIONAL 1-arm NCT03709641

A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion

A Single-Arm, Single-Center, Randomized, Single-Masked Study to Evaluate Restylane Defyne for Canalicular Occlusion in Participants With Mild to Moderate Dry Eye Disease

Sponsor: John C Meyer, MD

Conditions Mild to Moderate Dry Eye Disease

Interventions Restylane Defyne

Updated 6 times since 2018 Last updated: Dec 7, 2018 Started: Oct 17, 2018 Primary completion: Nov 28, 2018 Completion: Nov 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Mild to Moderate Dry Eye Disease and is currently completed. John C Meyer, MD leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA
Jan 2019 — Feb 2020 [monthly]

Completed NA

Status: Enrolling By Invitation → Completed

▶ Show 1 earlier version

Nov 2018 — Jan 2019 [monthly]

Enrolling By Invitation NA

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

John C Meyer, MD

Data source: The Eye Care Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Louisville, United States